EX-23.3 4 tv482879_ex23-3.htm EXHIBIT 23.3

Exhibit 23.3


Consent of Independent Registered Public Accounting Firm


We consent to the incorporation by reference in the Registration Statement on Form S-8 of Eloxx Pharmaceuticals, Inc. of our report dated October 13, 2017, relating to the consolidated financial statements of Sevion Therapeutics, Inc., appearing in the Annual Report on Form 10-K of Sevion Therapeutics, Inc. for the year ended June 30, 2017.


New York, NY  
January 10, 2018